A 67-year-old man with chronic bronchitis presents with increased sputum purulence, dyspnoea and sputum volume. He has an FEV1 of 45% predicted and usually uses a LAMA inhaler. According to COPD exacerbation management recommendations, what is the most appropriate treatment addition?